EQS-Adhoc: Vitruvia Medical AG: Issue of 6.00% Convertibel Bond 2022-2025

  • 87

EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Financing
Vitruvia Medical AG: Issue of 6.00% Convertibel Bond 2022-2025

26-Nov-2022 / 16:43 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


  

 

Convertible bond Vitruvia Medical AG ("Private Placement") 6.00% 2022-2025

 

By resolution of the Board of Directors, Vitruvia Medical AG has resolved to issue a convertible bond ("Private Placement") of CHF 2.2 million at an interest rate of 6.00% p.a. and a term of 3 years. The issue price is set at 100% and the conversion price is EUR 2.50 and is convertible into registered shares of Vitruvia Medical AG.

The funds will be used to finance existing projects (LT technologies GmbH & Co. KG), acquisitions (rebuilding of the investment portfolio) and general corporate financing.

 

Anglikon, 26 November 2022

Vitruvia Medical Ltd.

Board of directors

 

 

 


26-Nov-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Vitruvia Medical AG
Kesselackerstr. 18
5611 Anglikon
Switzerland
Phone: +41 44 915 33 78
E-mail: [email protected]
Internet: www.vitruvia-med.com
ISIN: CH0461931419
WKN: A2PDWF
Listed: Regulated Unofficial Market in Munich
EQS News ID: 1498163

 
End of Announcement EQS News Service

1498163  26-Nov-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1498163&application_name=news&site_id=centralchart
EQS Group
EQS Group

EQS Group is a leading international technology provider for Digital Investor Relations, Corporate Communications and Compliance. More than 8,000 companies worldwide trust EQS’s products and services to securely, efficiently, and simultaneously fulfil complex national and international disclosure and compliance requirements, and to reach stakeholders globally.